Skip Over Navigation Links


Template Agreements

Diagram of identifying new therapies for patients through (1) pharma, which create drugs, provide agents, sign agreements with researchers and form alliances with NIH/NCATS; (2) researchers, who provide new therapeutic use ideas, access patient populations, conduct clinical trials, sign agreements with pharma and receive funding from NIH/NCATS; and (3) NIH/NCATS, which posts agent information, develops agreement templates, crowdsources ideas, provides funding to researchers and forms alliances with pharma.

Click for a larger view.

The template agreements for the Discovering New Therapeutic Uses for Existing Molecules program are available here. They are designed to streamline the legal and administrative process for partnering across multiple organizations. The agreements save time and effort as well as provide a roadmap for handling intellectual property used in or developed through the program. 

During the pilot program, the templates helped shorten the time required to establish public-private collaborations to about three months instead of the more typical nine months to one year.

Memorandum of Understanding

Confidential Disclosure Agreements

Collaborative Research Agreements

Related Links